Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Inventory: 2024-2025

Historic Inventory for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Sep 2025 value amounting to $7.1 million.

  • Day One Biopharmaceuticals' Inventory rose 158.17% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year increase of 158.17%. This contributed to the annual value of $3.3 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Day One Biopharmaceuticals' Inventory stood at $7.1 million, which was up 7.92% from $6.5 million recorded in Q2 2025.
  • Day One Biopharmaceuticals' Inventory's 5-year high stood at $7.1 million during Q3 2025, with a 5-year trough of $151,000 in Q2 2024.
  • Its 2-year average for Inventory is $3.9 million, with a median of $3.4 million in 2024.
  • Data for Day One Biopharmaceuticals' Inventory shows a peak YoY soared of 4,233.11% (in 2025) over the last 5 years.
  • Day One Biopharmaceuticals' Inventory (Quarterly) stood at $3.3 million in 2024, then skyrocketed by 158.17% to $7.1 million in 2025.
  • Its Inventory stands at $7.1 million for Q3 2025, versus $6.5 million for Q2 2025 and $3.6 million for Q1 2025.